📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Immunex

1.1 - Company Overview

Immunex Logo

Immunex

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutic products for cancer, infectious diseases, and autoimmune disorders. Develops, manufactures, and markets treatments including Enbrel for rheumatoid arthritis and Novantrone for acute nonlymphocytic leukemia and pain associated with prostate cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Immunex

Instil Bio Logo

Instil Bio

HQ: United States Website
  • Description: Provider of cell therapy solutions focused on tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers, advancing proprietary manufacturing expertise, technology, and data into clinical trials. Programs include a planned registrational study and a first-in-human next-generation engineered TIL, plus FRα CoStAR, a clinical-stage candidate for non-small cell lung cancer (NSCLC).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Instil Bio company profile →
Kymab Logo

Kymab

HQ: United Kingdom Website
  • Description: Provider of fully human monoclonal antibody therapeutics focused on immune-mediated diseases and immuno-oncology, developed using proprietary, integrated IntelliSelect platforms. IntelliSelect Transgenic platforms contain a full diversity of human antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kymab company profile →
The Medicines Company Logo

The Medicines Company

HQ: United States Website
  • Description: Provider of innovative, cost-effective medicines to the worldwide hospital marketplace, focused on advancing treatment of critical care patients. Markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full The Medicines Company company profile →
Genzyme Logo

Genzyme

HQ: United States Website
  • Description: Provider of biotechnology products and services focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease, operating across four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery, and Hematologic Oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genzyme company profile →
Celgene Logo

Celgene

HQ: United States Website
  • Description: Provider of innovative biopharmaceutical therapies focused on the discovery, development and commercialization of treatments for cancer and immune-inflammatory-related diseases, serving patients with limited treatment options, with hundreds of clinical trials at major medical centers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Celgene company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Immunex

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Immunex

2.2 - Growth funds investing in similar companies to Immunex

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Immunex

4.2 - Public trading comparable groups for Immunex

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Immunex

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Immunex

What does Immunex do?

Immunex is a provider of therapeutic products for cancer, infectious diseases, and autoimmune disorders. Develops, manufactures, and markets treatments including Enbrel for rheumatoid arthritis and Novantrone for acute nonlymphocytic leukemia and pain associated with prostate cancer.

Who are Immunex's competitors?

Immunex's competitors and similar companies include Instil Bio, Kymab, The Medicines Company, Genzyme, and Celgene.

Where is Immunex headquartered?

Immunex is headquartered in United States.

How many employees does Immunex have?

Immunex has 1,000 employees 🔒.

When was Immunex founded?

Immunex was founded in 2010 🔒.

What sector and industry vertical is Immunex in?

Immunex is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Immunex

Who are the top strategic acquirers in Immunex's sector and industry

Top strategic M&A buyers and acquirers in Immunex's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Immunex?

Top strategic M&A buyers groups and sectors for Immunex include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Immunex's sector and industry vertical

Which are the top PE firms investing in Immunex's sector and industry vertical?

Top PE firms investing in Immunex's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Immunex's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Immunex's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Immunex's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Immunex include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Immunex's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Immunex?

The key public trading comparables and valuation benchmarks for Immunex include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Immunex for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Immunex with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Immunex's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Immunex with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Immunex's' sector and industry vertical?

Access recent funding rounds and capital raises in Immunex's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Immunex